Patient Information:

• Name: Mr. Li
• Diagnosis: Type II Diabetes Mellitus
• Date of Birth (D.O.B): August 1, 1956
• Gender: Male
• Country: China

Treatment: Cellular Immune Therapy for Type II Diabetes combined with Nerve Growth Factor Treatment, Physical Therapy, Traditional Chinese Medicine (TCM), and Metabolic Control Management at Kindgrove International Hospital (BPIH)

Medical History:
Mr. Li was admitted to BPIH due to Type II Diabetes of eight years duration.

Medical Condition before Cellular Immune Therapy for Type II Diabetes:

• Symptoms:
  • Insulin dependence: injections before meals daily
  • Poor sleep quality
  • Abnormal thirst
  • Nocturia
  • Blurred vision
• Medications:
  • Metformin
  • Phenformin
  • Insulin injections
• Laboratory Results (admission):
  • HbA1c: 9.5%
  • Fasting Blood Glucose (FBG): 14.0 mmol/L (252 mg/dL)
  • Postprandial Blood Glucose (PBG): 25.9 mmol/L (467 mg/dL)

Cellular Immune Therapy for Type II Diabetes:

• Medical protocols applied:
  • Cellular immune therapy to repair injured pancreatic islet cells
  • Metabolic function improvement and blood sugar control management
  • Traditional Chinese medicine (TCM)
  • Rehabilitation therapy

Physical Condition after Cellular Immune Therapy for Type II Diabetes (post-therapy):

• Improved laboratory results:
  • HbA1c: 7.6%
  • FBG: 9.4 mmol/L (170 mg/dL) – a decrease of 4.6 mmol/L (82 mg/dL)
  • PBG: 10.0 mmol/L (180 mg/dL) – a decrease of 15.9 mmol/L (287 mg/dL)
• Successful insulin discontinuation
• Improved oral medications for blood sugar control only
• Improved sleep quality
• Significant alleviation of symptoms:
  • Abnormal thirst
  • Nocturia
  • Blurred vision